We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Tuesday, April 15, 2025
The Food and Drug Administration must evaluate the risks posed if genetically engineered salmon escape into the wild, a federal judge said in a case involving FDA’s 2015 approval of AquaBounty’s plans to create and farm GE Atlantic salmon.